Source of funding and outcome of clinical trials

Cited by (397)

Items 201–300 of 397

1. University-Industry Relationships: Framing the Issues for Academic Research in Agricultural Biotechnology
   David E. Ervin, Terri L. Lomax, Steven T. Buccola, Kristin Kim, Elizabeth C. Minor, Yang Hui, Leland Glenna, Elizabeth L. Jaeger, Dina Biscotti, Walter J. Armbruster et al. · 2002 · PDXScholar (Portland State University)
2. Industry-Funded Dermatologic Research Within Academia in the United States: Fiscal and Ethical Considerations
   Irvin H. Blank · 1992 · Journal of Investigative Dermatology
3. Conflicts of Interest in Magnetic Resonance Imaging: Issues in Clinical Practice and Research
   Mildred K. Cho · 2002 · Topics in Magnetic Resonance Imaging
4. Science of Uncertainty: Making Cases for Drug Incorporation in Brazil
   Alex K. Gertner · 2010 · Anthropological Quarterly
5. Is evidence-based medicine a gold standard or can it be influenced?
   Vitull Kumar Gupta, Praneet Wander, Meghna Gupta · 2016 · Indian Heart Journal
6. Pharmaceutical companies and medical practitioners or “the beast and the beauty”?
   Luis Javier García Villalba · 2018 · Clinics in Dermatology
7. The benefits and threats of research partnerships with industry
   G. Duval · 2005 · Critical Care
8. Commercial support and bias in pharmaceutical research
   C. Seth Landefeld · 2004 · The American Journal of Medicine
9. Should doctors be prescribing new drugs?
   Joel Lexchin · 2002 · International Journal of Risk & Safety in Medicine
10. Ten Steps to Developing a National Agenda to Address Financial Conflicts of Interest in Industry Sponsored Clinical Research
    Patricia M. Tereskerz, J. Moreno · 2005 · Accountability in Research
11. Relationship Between Academia and Industry: Ethical Considerations☆☆☆★
    Paul M. Paris · 1996 · Annals of Emergency Medicine
12. Conflicts of Interest in Human Subject Research: The Insufficiency of U.S. and International Standards
    M. Rodwin · 2019 · American Journal of Law & Medicine
13. Association of industry sponsorship and positive outcome in randomised controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study
    Pascal Probst, Kathrin Grummich, Alexis B. Ulrich, Markus Wolfgang Büchler, Phillip Knebel, Markus K. Diener · 2014 · Systematic Reviews
14. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
    N. Goswami, E. Tsalik, S. Naggie, W. Miller, J. Horton, Christopher D. Pfeiffer, C. Hicks · 2014 · Trials
15. La prescription de médicaments psychotropes aux enfants et adolescents: Prévalence, politiques, pratiques et pistes de recherche.
    Denis Lafortune, Johanne Collin · 2006 · Canadian Psychology/Psychologie canadienne
16. Clinical research in the private office setting--ethical issues.
    Alan R. Fleischman, Jason E. Klein · 2002 · PubMed Central
17. Professional writing assistance: effects on biomedical publishing
    M. Lagnado · 2003 · Learned Publishing
18. Realities of trial registration: the Glaxo Wellcome experience
    Trevor J Gibbs, Elizabeth Wager · 2000 · International Journal of Pharmaceutical Medicine
19. Epidemiology and the World Wide Web: Is There a 'Net Benefit?
    Charles du V. Florey, Yoav Ben‐Shlomo, Matthias Egger · 2000 · Epidemiologic Reviews
20. Epidemiologic studies of adverse effects of anti‐retroviral drugs: how well is statistical power reported
    Scott D. Halpern, Todd D. Barton, Robert Gross, Sean Hennessy, Jesse A. Berlin, Brian L. Strom · 2004 · Pharmacoepidemiology and Drug Safety
21. No publication bias in industry funded clinical trials of degenerative diseases of the spine
    Colin Son, Samon Tavakoli, Viktor Bartanusz · 2015 · Journal of Clinical Neuroscience
22. Financial competing interests were associated with favorable conclusions and greater author productivity in nonsystematic reviews of neuraminidase inhibitors
    Adam G. Dunn, Xujuan Zhou, Joel D. Hudgins, Diana Arachi, Kenneth D. Mandl, Enrico W Coiera, Florence T. Bourgeois · 2016 · Journal of Clinical Epidemiology
23. Scientific Misconduct: The Perversion of Scientific Evidence for Policy Advocacy
    George H. Avery · 2010 · World Medical & Health Policy
24. The Decade of the Brain: 1990 to 2000
    Edward R. Laws · 2000 · Neurosurgery
25. Decision-makers′ use of pharmacoeconomics: what does the research tell us?
    Alan Lyles · 2001 · Expert Review of Pharmacoeconomics & Outcomes Research
26. Conflict of Interest and Commercialization of Biomedical Research
    Kathleen Cranley Glass, Trudo Lemmens · 1999 · Springer eBooks
27. Conflict of Interest: Art or Science?: The Hippocratic Solution
    James N. Weinstein · 2002 · Spine
28. Drug companies and information about drugs: recommendations for doctors
    C. Seth Landefeld, Mary‐Margaret Chren · 1996 · Journal of General Internal Medicine
29. Scientific Objectivity
    David B. Resnik · 2007
30. Research Program Peer Review: Purposes, Principles, Practices, Protocols
    Ronald Neil Kostoff · 2004 · Defense Technical Information Center (DTIC)
31. Money and the Norms of Science
    David B. Resnik · 2007
32. Therapeutic apheresis in neurological disorders
    Robert S. Weinstein · 2000 · Journal of Clinical Apheresis
33. Scientific uncertainty and the creation of resuscitation guidelines
    Stuart Nairn, Stephen Timmons · 2010 · Social Theory & Health
34. Meta-Analysis: Methodology, Utility, and Limitations
    M. Mancano, M. Bullano · 1998 · Journal of Pharmacy Practice
35. The adequacy of the ethics review process in Malaysia : protection of the interests of mentally incapacitated adults who enrol in clinical trials
    Sharon Kaur · 2011 · UCL Discovery (University College London)
36. Une épistémologie sociale peut-elle être aléthiste ?
    Pascal Engel · 2007 · Éditions de l’École des hautes études en sciences sociales eBooks
37. DO PHARMACEUTICAL COMPANIES SELECTIVELY REPORT CLINICAL TRIAL DATA
    Syed Ahmer, Imran Haider, Duncan Anderson, Pradeep Arya · 2006
38. A Case of Unexpected and Selective Remission of a 20-Year History of Ephedrine Dependence Following Treatment With Low-Dose Aripiprazole
    Karen Arnold, Joel Yager · 2007 · The Journal of Clinical Psychiatry
39. Industry-Sponsored Economic Studies in Critical and Intensive Care Versus Studies Sponsored by Nonprofit Organizations
    Michael Hartmann, Holger Knoth, Diane Schulz, Sven Knoth, Andreas Meier‐Hellmann · 2003 · Journal of Intensive Care Medicine
40. Pharmaceutical Industry Support of Psychiatric Research and Education: Ethical Issues and Proposed Remedies
    C. Goldman, D. Cutler · 2002 · Kluwer Academic Publishers eBooks
41. [Financial conflict of interest in clinical psychiatry studies: a review].
    Halis Ulaş, Tolga Binbay, Köksal Alptekın · 2008 · PubMed
42. Reply to Sertraline Versus Venlafaxine XR in Major Depressive Disorder
    Richard Charles Shelton · 2007 · The Journal of Clinical Psychiatry
43. Quality of Clinical Reports on Behavioral Interventions for Hypertension
    L. Ebony Boulware, Gail L. Daumit, Kevin D. Frick, Cynthia S. Minkovitz, Robert S. Lawrence, Neil R. Powe · 2002 · Preventive Medicine
44. Developing a mixed methods framework for process evaluations of complex interventions: the case of the National Exercise Referral Scheme Policy Trial in Wales
    Graham F Moore · 2010 · ORCA Online Research @Cardiff (Cardiff University)
45. Institutional Conflicts of Interest: Protecting Human Subjects, Scientific Integrity, and Institutional Accountability
    G. Duval · 2004 · Journal of Law, Medicine & Ethics
46. Trends in Disclosures of Industry Sponsorship
    Awad Allah Omer Mohamed Ahmed, Emma Brey Holliday, Mohamad Fakhreddine, Stella K. Yoo, Curtiland Deville, Reshma Jagsi · 2016 · International Journal of Radiation Oncology*Biology*Physics
47. The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials
    Srinivas Raman, Fábio Ynoe de Moraes, Lucas C. Mendez, Neil Kanth Taunk, John H. Suh, Luís Souhami, Ben J. Slotman, Paul N. Kongkham, Daniel Eidelberg Spratt, Alejandro Berlín et al. · 2018 · Journal of Neuro-Oncology
48. Étude observationnelle des déclarations de liens d’intérêts au Congrès de la médecine générale France et liens d’intérêts des médecins intervenants
    Adriaan Barbaroux, Guillaume C. Lardy · 2021 · Therapies
49. Funding sources and breast cancer research frame
    Wonkwang Jo · 2020 · PLoS ONE
50. Meta-analysis and Publication Bias in Medical Research
    Chikuma Hamada, Yushi Nakanishi, Nobushige Matsuoka · 2006 · Japanese Journal of Biometrics
51. What’s Wrong with Litigation-Driven Science?
    Susan Haack · 2014 · Cambridge University Press eBooks
52. Editorials: Ethical Conflicts for Physicians Treating ESRD Patients
    William M. Bennett · 2004 · Seminars in dialysis
53. Scientific Misconduct: The Manipulation of Evidence for Political Advocacy in Health Care and Climate Policy
    George H. Avery · 2010 · SSRN Electronic Journal
54. Aplicação dos Princípios da Medicina Baseada em Evidências em Programas de Avaliação de Procedimentos e Medicamentos de Alto Custo
    Edimar Alcides Bocchi, José Antonio, M. F. De Carvalho Neto · 2001
55. Evidence-Based Drug Use in Equine Medicine and Surgery
    Joseph J. Bertone · 2007 · Veterinary Clinics of North America Equine Practice
56. Clinical trials in otology: Examining trends and framework for prioritization
    J. Altshuler, Rohan Viswanathan, Divya B. Dasani, Katherine L. Webb, Tam Ramsey, Varun Patel, Randall Ruffner, J. Mouzakes, D. Foyt · 2020 · Journal of Otology
57. Role of industry sponsorship and research outcomes of myopia control interventions
    Jia-Yan Kai, Huimin Chen, Xing‐Xuan Dong, Dan‐Lin Li, Carla Lança, Andrzej E. Grzybowski, Chen‐Wei Pan · 2025 · British Journal of Ophthalmology
58. ETHICALLY PRACTICED UNETHICAL STRATEGIES IN PHARMA INDUSTRY - WHOM TO BE BLAMED
    V. Sasirekha · 2018 · International Journal of Research -GRANTHAALAYAH
59. Construction de systèmes de croyances et controverses autour du Covid-19
    Gérard Mondello · 2022 · Revue d économie politique
60. EPA's Stage 2 Disinfection Byproducts Rules (DBPR) and Northern Kentucky Water: An Economic and Scientific Review
    Hugh Henry · 2013 · Dose-Response
61. The Precautionary Principle
    Peter Saunders · 2002
62. Industry-funded clinical trials: Beneficial or harmful?
    Jing Zhang, Yiping Yuan · 2015 · Clinical Research and Regulatory Affairs
63. Balancing cost-effectiveness with quality in tissue viability
    Debbie Norman · 2003 · British Journal of Nursing
64. The Use of Metaanalysis in Pharmacoepidemiology
    Jesse A. Berlin, Brenda J. Crowe, H. Amy Xia, Stephen J. W. Evans · 2019 · Pharmacoepidemiology
65. The Use of Meta‐analysis in Pharmacoepidemiology
    Jesse A. Berlin, Soledad Cepeda, Carin J. Kim · 2012 · Pharmacoepidemiology
66. Change in opioid use following spinal cord stimulation: a systematic review and meta-analysis
    Hunter Soleymani, Mahmoud Morsi, Kira Kopacz, Jay V. Karri, Lisa Goudman, Nasir Hussain, Saba Javed, Ryan Steven D'Souza · 2026 · Regional Anesthesia & Pain Medicine
67. El sesgo de publicación en medicina.
    Juan Miyahira Arakaki · 2013 · Revista Médica Herediana
68. Funding and Bias
    Christina A. Di Bartolo, M. Braun · 2017 · Springer eBooks
69. An Archeology of Corruption in Medicine
    M. Little, W. Lipworth, I. Kerridge · 2022 · Journal of Bioethical Inquiry
70. Systematic reviews: Not always a pain
    A. Fogarty, Aaron M. Conger, Taylor Burnham · 2022 · Interventional Pain Medicine
71. La integridad de la ciencia: significado e importancia
    Susan Haack · 2007 · Contrastes Revista Internacional de Filosofía
72. Scientific misconduct in the pharmaceutical industry
    Marie-Louise Hoogendoorn, Anouk de Lange · 2013 · Utrecht University Repository (Utrecht University)
73. Publication Bias and the Market Orientation-Performance Nexus Literature
    Kwaku Appiah‐Adu, Justice Gameli Djokoto · 2015 · Journal of Management and Research
74. Outcomes of a Trial of HIV-1 Immunogen in Patients With HIV Infection
    Billi Goldberg, Raphael B. Stricker · 2001 · JAMA
75. INVITED PAPER: Customer and consumer confidence in the livestock industry—Professional ethics
    Lawrence D. Bunting, M. L. Galyean · 2015 · The Professional Animal Scientist
76. Relationship Between Declarations of Conflict of Interests and Reporting Positive Outcomes in Iranian Dental Journals
    Maryam Alsadat Hashemipour, Sepehr Pourmonajemzadeh, Shahrzad Zoghi Tavana, Nader Navabi · 2018 · Science and Engineering Ethics
77. Funding Source, Quality of Publications and Outcome in Genetic Damage in Mammalian Cells Exposed to Non-Ionizing Radiofrequency Fields
    Vijayalaxmi Vijayalaxmi, Thomas J. Prihoda · 2019 · Radiation Research
78. Experiments in policing: The challenge of context
    Ben Bradford, Chris Giacomantonio, Sarah MacQueen · 2018 · European Journal of Policing Studies
79. Industry or academia: Who leads the research in medicine?
    Natale Daniele Brunetti, Luisa De Gennaro, Pier Luigi Pellegrino, Matteo Di Biase · 2007 · European Journal of Internal Medicine
80. Por que as pesquisas financiadas pela indústria farmacêutica mostram resultados mais favoráveis aos seus produtos?
    Moacyr Roberto Cucê Nobre, Wanderley Marques Bernardo, Fábio Biscegli Jatene · 2004 · Revista da Associação Médica Brasileira
81. Reply to Acupuncture for Major Depressive Disorder
    Rosa N. Schnyer, Andrea S. Chambers · 2007 · The Journal of Clinical Psychiatry
82. Public welfare agenda or corporate research agenda?
    Ajai R Singh, ShakuntalaA Singh · 2005 · Mens Sana monographs
83. Cultivating a Healthy Journal Space
    Sangwon Suh · 2006 · The International Journal of Life Cycle Assessment
84. 9. Pharmacoepidemiology and the Law
    A. Kesselheim · 2012 · Pharmacoepidemiology
85. Is Article Methodological Quality Associated With Conflicts of Interest?
    Brian Cho, Joseph Lopez, Jessica J. Means, Sandra Lopez, Jacqueline N. Milton, Anthony P. Tufaro, James Warren May, Amir H. Dorafshar · 2017 · Annals of Plastic Surgery
86. Conflicts of Interest and Scientific Objectivity
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
87. Disseminating the Results
    Andrew Thompson, Matthias Egger · 2001 · Springer eBooks
88. Post market Research of Oral Anti-Diabetic Drugs: Metformin, Glipizide, and Pioglitazone
    Nabil Khalidi, Bassam Atallah, Abdulmalik M. Alkatheri, Abdulkareem M. Albekairy, Amjad M. Qandil · 2014 · Journal of Applied Pharmaceutical Science
89. Ethical issues related to receiving research funding from the alcohol industry and other commercial interests
    Thomas F. Babor, Katherine Robaina · 2012 · Cambridge University Press eBooks
90. Communication of research findings in peer-reviewed journals: publication bias, timing of publication, conflicting interests and fraud
    M. Szklo · 1996 · The Science of The Total Environment
91. Extend the Reach of Institutional Review Boards First, Then Strengthen Their Depth
    Jeffrey Philip Spike · 2008 · The American Journal of Bioethics
92. Biomedical Research: A Systematic Review Scope and Impact of Financial Conflicts of Interest in
    Justin E. Bekelman, Yan Li, Cary Philip Gross · 2010
93. Dawning of a new era for acute stroke therapy
    David M. Pelz, Sachin Kishore Pandey, Stephen P. Lownie · 2015 · Journal of NeuroInterventional Surgery
94. Publication and Peer Review
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
95. Misconduct in Research
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
96. Conflict of Interest, Bias, and Manipulation: Reassessing Prescriber Education and the Learned Intermediary Doctrine
    Michael P. Pagano · 2010 · DigitalCommons - Fairfield (Fairfield University)
97. La relación entre la medicina y los proveedores médicos
    Andrés Heerlein · 2014 · Revista médica de Chile
98. Patent-holders on expert committees. Can there be a conflict of interest?
    Erik Thorstensen · 2015 · Etikk i praksis - Nordic Journal of Applied Ethics
99. Longitudinal Stability of Effect Sizes in Education Research
    Joshua Stephens · 2016 · Journal of Modern Applied Statistical Methods
100. The Norms of Science
     David B. Resnik · 2007